292 related articles for article (PubMed ID: 36612904)
1. Risk of Lichen Sclerosus and Lichen Planus in Patients Receiving Immune Checkpoint Inhibitors.
Alharbi A; Khobrani A; Noor A; Alghamdi W; Alotaibi A; Alnuhait M; Haseeb A
Int J Environ Res Public Health; 2022 Dec; 20(1):. PubMed ID: 36612904
[TBL] [Abstract][Full Text] [Related]
2. Comorbid Vulvar Lichen Planus and Lichen Sclerosus.
Day T; Moore S; Bohl TG; Scurry J
J Low Genit Tract Dis; 2017 Jul; 21(3):204-208. PubMed ID: 28369011
[TBL] [Abstract][Full Text] [Related]
3. Risk of Vulvar Squamous Cell Carcinoma in Lichen Sclerosus and Lichen Planus: A Systematic Review.
Leis M; Singh A; Li C; Ahluwalia R; Fleming P; Lynde CW
J Obstet Gynaecol Can; 2022 Feb; 44(2):182-192. PubMed ID: 34678521
[TBL] [Abstract][Full Text] [Related]
4. The association of lichen sclerosus and erosive lichen planus of the vulva with autoimmune disease: a case-control study.
Cooper SM; Ali I; Baldo M; Wojnarowska F
Arch Dermatol; 2008 Nov; 144(11):1432-5. PubMed ID: 19015417
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of genital self-image and sexual dysfunction in women with vulvar lichen planus or lichen sclerosus.
Yıldız Ş; Cengiz H; Kaya C; Alay İ; Öztürk E; Tunca AF; Erdoğan A; Yaşar L
J Psychosom Obstet Gynaecol; 2022 Jun; 43(2):99-106. PubMed ID: 33297796
[TBL] [Abstract][Full Text] [Related]
6. Lichen sclerosus and lichen planus: a spectrum of disease? Report of two cases and review of the literature.
Holmes SC; Burden AD
Clin Exp Dermatol; 1998 May; 23(3):129-31. PubMed ID: 9861744
[TBL] [Abstract][Full Text] [Related]
7. Perianal lichen dermatoses: A review of 60 cases.
Day T; Bohl TG; Scurry J
Australas J Dermatol; 2016 Aug; 57(3):210-5. PubMed ID: 25752318
[TBL] [Abstract][Full Text] [Related]
8. Is Vulvovaginal Lichen Planus Associated With Squamous Cell Carcinoma?
Day T; Otton G; Jaaback K; Weigner J; Scurry J
J Low Genit Tract Dis; 2018 Apr; 22(2):159-165. PubMed ID: 29470358
[TBL] [Abstract][Full Text] [Related]
9. Real-world safety experience with immune checkpoint inhibitors in Saudi Arabia.
Al Nuhait M; Bajnaid E; Al Otaibi A; Al Shammari A; Al Awlah Y
Sci Prog; 2021; 104(1):36850421997302. PubMed ID: 33689534
[No Abstract] [Full Text] [Related]
10. Anogenital High-Grade Squamous Intraepithelial Lesion Comorbid With Vulvar Lichen Sclerosus and Lichen Planus.
Lin A; Day T; Ius Y; Scurry J
J Low Genit Tract Dis; 2020 Jul; 24(3):311-316. PubMed ID: 32324694
[TBL] [Abstract][Full Text] [Related]
11. Immune checkpoint inhibitor-induced pure red cell aplasia: Case series and large-scale pharmacovigilance analysis.
Guo Q; Gao J; Guo H; Xie J; Cheng J
Int Immunopharmacol; 2023 Jan; 114():109490. PubMed ID: 36459923
[TBL] [Abstract][Full Text] [Related]
12. Nivolumab-related lichen planus of the lip in a patient with head and neck cancer.
Economopoulou P; Nicolatou-Galitis O; Kotsantis I; Psyrri A
Oral Oncol; 2020 May; 104():104623. PubMed ID: 32144002
[TBL] [Abstract][Full Text] [Related]
13. Vulvar Lichenoid Dermatoses With Emphasis on the Distinction Between Lichen Sclerosus and Lichen Planus: A 10-Year Study.
D'Souza SL; Ravikumar G; Antony M; Tirumale R
J Low Genit Tract Dis; 2024 Apr; 28(2):189-197. PubMed ID: 38518217
[TBL] [Abstract][Full Text] [Related]
14. Acquired thrombotic thrombocytopenic purpura associated with immune checkpoint inhibitors: A real-world study of the FDA adverse event reporting system.
Moore DC; Elmes JB; Arnall JR; Strassels SA; Patel JN
Int Immunopharmacol; 2022 Sep; 110():109015. PubMed ID: 35803131
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of uveitis events in real-world patients receiving immune checkpoint inhibitors based on the FAERS database.
Fan Q; Chen H; Hu Y; Zhao B
Cutan Ocul Toxicol; 2023 Jun; 42(2):68-73. PubMed ID: 37130046
[TBL] [Abstract][Full Text] [Related]
16. Light microscopic criteria for the diagnosis of early vulvar lichen sclerosus: a comparison with lichen planus.
Fung MA; LeBoit PE
Am J Surg Pathol; 1998 Apr; 22(4):473-8. PubMed ID: 9537476
[TBL] [Abstract][Full Text] [Related]
17. PD-1/PD-L1 inhibitor-induced immune thrombocytopenia: A pharmacovigilance study and systematic review.
Moore DC; Elmes JB; Arnall JR; Strassel SA; Patel JN
Int Immunopharmacol; 2024 Mar; 129():111606. PubMed ID: 38359661
[TBL] [Abstract][Full Text] [Related]
18. Renal adverse effects following the use of different immune checkpoint inhibitor regimens: A real-world pharmacoepidemiology study of post-marketing surveillance data.
Chen G; Qin Y; Fan QQ; Zhao B; Mei D; Li XM
Cancer Med; 2020 Sep; 9(18):6576-6585. PubMed ID: 32720449
[TBL] [Abstract][Full Text] [Related]
19. Risk factors of immune checkpoint inhibitor-associated acute kidney injury: evidence from clinical studies and FDA pharmacovigilance database.
Chen P; Zhu J; Xu Y; Huang Q; Su J; Gao Z; Feng M
BMC Nephrol; 2023 Apr; 24(1):107. PubMed ID: 37087434
[TBL] [Abstract][Full Text] [Related]
20. Frontal fibrosing alopecia and genital Lichen sclerosus: Single-center experience.
Grassi S; Tadiotto Cicogna G; Magri F; Caterina Fortuna M; Caro G; Pernazza A; Soda G; Miraglia E; Giustini S; Carlesimo M; Rossi A
J Cosmet Dermatol; 2021 Feb; 20(2):615-620. PubMed ID: 32590887
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
